These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23848176)

  • 61. Single-dose tranexamic acid in advanced ovarian cancer surgery reduces blood loss and transfusions: double-blind placebo-controlled randomized multicenter study.
    Lundin ES; Johansson T; Zachrisson H; Leandersson U; Bäckman F; Falknäs L; Kjølhede P
    Acta Obstet Gynecol Scand; 2014 Apr; 93(4):335-44. PubMed ID: 24428857
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Influence of different tranexamic acid administration methods during and after cardiac surgery on coagulation function and postoperative blood loss].
    Wang JJ; Chen GJ; Liu W; Huang YG; Luo AL; Miao Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):145-9. PubMed ID: 23643001
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of topical tranexamic acid in open heart surgery.
    Abul-Azm A; Abdullah KM
    Eur J Anaesthesiol; 2006 May; 23(5):380-4. PubMed ID: 16438759
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial).
    Bokesch PM; Szabo G; Wojdyga R; Grocott HP; Smith PK; Mazer CD; Vetticaden S; Wheeler A; Levy JH
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1022-9. PubMed ID: 21724197
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass.
    Waldow T; Krutzsch D; Wils M; Plötze K; Matschke K
    Clin Hemorheol Microcirc; 2009; 42(4):269-77. PubMed ID: 19628892
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Tranexamic acid reduces haematomas but not pain after total knee arthroplasty].
    Chevet I; Remérand F; Couvret C; Baud A; Pouplard C; Rosset P; Laffon M; Fusciardi J
    Ann Fr Anesth Reanim; 2011 Jan; 30(1):17-24. PubMed ID: 21215592
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tranexamic acid reduces blood loss after cementless total hip arthroplasty-prospective randomized study in 40 cases.
    Yamasaki S; Masuhara K; Fuji T
    Int Orthop; 2004 Apr; 28(2):69-73. PubMed ID: 15224162
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied.
    Alvarez JC; Santiveri FX; Ramos I; Vela E; Puig L; Escolano F
    Transfusion; 2008 Mar; 48(3):519-25. PubMed ID: 18067499
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.
    Khemis A; Kaiafa A; Queille-Roussel C; Duteil L; Ortonne JP
    Br J Dermatol; 2007 May; 156(5):997-1004. PubMed ID: 17388924
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery.
    Sindet-Pedersen S; Ramström G; Bernvil S; Blombäck M
    N Engl J Med; 1989 Mar; 320(13):840-3. PubMed ID: 2648144
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Topical application of tranexamic acid after adenoidectomy: a double-blind, prospective, randomized, controlled study.
    Albirmawy OA; Saafan ME; Shehata EM; Basuni AS; Eldaba AA
    Int J Pediatr Otorhinolaryngol; 2013 Jul; 77(7):1139-42. PubMed ID: 23669000
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Clinical studies of the therapeutic effectiveness of the combination of tranexamic acid and antibiotics in otorhinolaryngology].
    Redaelli GA; D'Ascanio GF; Ferrarini A; Poma A
    Clin Ter; 1981 Feb; 96(3):271-81. PubMed ID: 7307447
    [No Abstract]   [Full Text] [Related]  

  • 73. Topical isotretinoin for melasma in Thai patients: a vehicle-controlled clinical trial.
    Leenutaphong V; Nettakul A; Rattanasuwon P
    J Med Assoc Thai; 1999 Sep; 82(9):868-75. PubMed ID: 10561942
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The use of tranexamic acid to reduce postoperative bleeding following cardiac surgery: a double-blind randomized trial.
    Coffey A; Pittmam J; Halbrook H; Fehrenbacher J; Beckman D; Hormuth D
    Am Surg; 1995 Jul; 61(7):566-8. PubMed ID: 7793735
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Treatment of menorrhagia with tranexamic acid. A clinical trial of an underestimated problem in general practice].
    Drøsdal H
    Tidsskr Nor Laegeforen; 1993 Sep; 113(23):2907-10. PubMed ID: 8236193
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial.
    Chandra B
    Ann Neurol; 1978 Jun; 3(6):502-4. PubMed ID: 354483
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Review of Oral Therapies for the Treatment of Skin Hyperpigmentation.
    Shimshak SJE; Tolaymat LM; Haga CB; Dawson NL; Gillis MS; Yin M; Kirsch B; Cooper M; Sluzevich JC
    J Cutan Med Surg; 2022; 26(2):169-175. PubMed ID: 34541912
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Treatment of mild to moderate facial melasma with the Lumixyl topical brightening system.
    Hantash BM; Jimenez F
    J Drugs Dermatol; 2012 May; 11(5):660-2. PubMed ID: 22527440
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Efficacy of dioic acid compared with hydroquinone in the treatment of melasma.
    Tirado-Sánchez A; Santamaría-Román A; Ponce-Olivera RM
    Int J Dermatol; 2009 Aug; 48(8):893-5. PubMed ID: 19659872
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Refining the management of hyperpigmentary disorders.
    Ali FR; Al-Niaimi F
    Clin Exp Dermatol; 2020 Dec; 45(8):1063. PubMed ID: 32356613
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.